Skip to content
lifestyle.projectdiaspora.org
Animals
Auto
Beauty & Style
Business News
Entertainment
Food
Health
Home & Family
Podcasts
Tech
Travel
Author:
DBV Technologies S.A.
DBV Technologies to Present New Positive Data from VITESSE Study and Preview Recently Initiated THRIVE Study at the EAACI Congress 2026
June 8, 2026
DBV Technologies to Participate in the Goldman Sachs 47th Annual Global Healthcare Conference
June 5, 2026
DBV Technologies Announces the Results of its 2026 Combined General Meeting
June 3, 2026
Information Regarding the Total Number of Voting Rights and Total Number of Shares of the Company as of May 31, 2026
June 3, 2026
DBV Technologies Announces First Participant Screened in THRIVE Phase 2 Study of the VIASKIN® Peanut Patch in Infants ages 6 through 12 Months with Peanut Allergy
June 2, 2026
Combined General Meeting of June 3, 2026
May 21, 2026
DBV Technologies to Participate in the H.C. Wainwright 4th Annual BioConnect Investor Conference at Nasdaq
May 21, 2026
DBV Technologies Reports First Quarter 2026 Financial Results
May 6, 2026
Information Regarding the Total Number of Voting Rights and Total Number of Shares of the Company as of March 31, 2026
May 3, 2026
DBV Technologies to Join CAC Mid 60 and SBF 120 Indices Following Euronext Paris Annual Review
May 1, 2026
1
2
Next Page
→